Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03671291Not ApplicableCompleted

Missed Opportunities to Pre-exposure Prophylaxis for HIV Infection on Person Newly Diagnosed With HIV

Role: collaborator

NCT04884048Completed

Multicentric Bone Tumor Imaging Report and Data System

Role: collaborator

NCT03004651Completed

BMI and Ultrasound/Clinical Assessments of RA Disease Activity

Role: collaborator

NCT02832661Unknown

BIOMARGIN European, Ambispective Cohort of Adult and Paediatric Renal Transplant Patients

Role: collaborator

NCT00479843Not ApplicableCompleted

Nutritional Programme for Dementia Elderly Patient

Role: collaborator

All 5 trials loaded